All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 105 of 206 pages ‹ First < 103 104 105 106 107 > Last ›
HSL13621
Stein R.
Im Netz des Marketings
Der Tagesspiegel 2006 Sep 12
http://www.tagesspiegel.de/magazin/wissen/gesundheit/;art300,2039385
HSL6064
Rumleski K.
Former drug rep has horror stories to tell
London Free Press 2006 Sep 11
http://lfpress.ca/newsstand/Today/Books/2006/09/11/1825001-sun.html
HSL6058
Side effects you don't hear about
Seattle Times 2006 Sep 10
http://archives.seattletimes.nwsource.com/cgi-bin/texis.cgi/web/vortex/display?slug=healthsleepingpills10&date=20060910&query=sleeping+pills
HSL6059
McVicar N.
A sleep aid wake-up call
Seattle Times 2006 Sep 10
http://archives.seattletimes.nwsource.com/cgi-bin/texis.cgi/web/vortex/display?slug=healthsleep10&date=20060910&query=sleeping+pills
HSL6065
Antidepressant drugs linked to increased risk of death for heart patients
Xagena 2006 Sep 10
http://www.xagena.it/news/medicinenews_net_news/3ee99048971f0284e4c36e56c2502977.html
HSL6066
Feder B.
Battle Lines in Treating Depression
New York Times 2006 Sep 10
http://www.nytimes.com/2006/09/10/business/yourmoney/10cyber.html?_r=1&th=&oref=slogin&emc=th&pagewanted=print
HSL6166
Brettingham M.
Roche employee wins partial victory.
BMJ 2006 Sep 9;333:(7567):515
http://bmj.bmjjournals.com/cgi/content/full/333/7567/515-ahttp://
HSL7093
Brettingham M.
Roche employee wins partial victory.
BMJ 2006 Sep 9;333:(7567):515
http://www.bmj.com/cgi/content/full/333/7567/515-a
HSL7094
Charatan F.
US judge dismisses 50m dollars damages in Vioxx lawsuit.
BMJ 2006 Sep 9;333:(7567):516
http://www.bmj.com/cgi/content/full/333/7567/516-c
HSL7099
Schuwirth LW, van der Vleuten CP.
Challenges for educationalists.
BMJ 2006 Sep 9;333:(7567):544-6
http://www.bmj.com/cgi/content/short/333/7567/544
HSL6015
TV Guide : Episode 102 : A Bitter Pill
PBS TV 2006 Sep 8
http://www.pbs.org/wnet/air/episodes_102.html
HSL6067
Elderly 'at risk of drug errors'
BBC News 2006 Sep 8
http://news.bbc.co.uk/1/hi/health/5321450.stm
HSL6069
Korczak V.
What's wrong with pushing pills?
New Matilda 2006 Sep 8
http://www.google.com.au/url?sa=t&rct=j&q=a%20consumer%20complaint%20about%20pharmaceutical%20advertising%20reveals%20the%20%0Ainadequacy%20of%20the%20medicines%20australia%20(ma)%20code%20of%20conduct%20that%20%0Aregulates%20the%20marketing%20of%20drugs%20in%20australia.%20while%20direct%20to%20consumer%20%0Aadvertising%20is%20prohibited%20in%20australia%2C%20companies%20are%20employing%20%0Aincreasingly%20novel%20marketing%20techniques%20to%20reach%20consumers%20and%20are%20%0Asucceeding.%20the%20code%20needs%20to%20be%20strengthened%2C%20starting%20with%20higher%20%0Asanctions%20and%20more%20effective%20monitoring.%20failing%20this%2C%20new%20legislation%20%0Aneeds%20to%20be%20introduced%20and%20enforced%20through%20an%20appropriate%20regulator.&source=web&cd=1&ved=0CCEQFjAA&url=http%3A%2F%2Fwww.choice.com.au%2F~%2Fmedia%2Ffiles%2Fconsumer%2520action%2Fhealth%2Fdrug%2520advertising%2Ff126086.ashx&ei=iVoWT8S8DaahiAfm87jhAw&usg=AFQjCNGzwV8sHo7LOXv6B-ZcHnQNDvtKzA&sig2=RlCrwOAn2628tPWhpR1DeQ&cad=rja
HSL6417
Hopkins Conflicts of Interest Study: Researchers Don't Want toDisclose $$
Johns Hopkins University 2006 Sep 8
HSL19917
Smith P
Lobster back on ice - for now
Australian Doctor 2006 Sep 85
HSL20037
Saunders C
Hard Sell: Drug reps can be a useful source of information if used the right way
Australian Doctor 2006 Sep 847-48
HSL6146
Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ.
An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
JAMA 2006 Sep 6;296:(9):1086-93
http://jama.ama-assn.org/cgi/content/full/296/9/1086
HSL6162
Saunders C.
Drug reps can be a useful source of information if used the right way
Australian Doctor 2006 Sep 6;
http://www.australiandoctor.com.au/news/9a/0c043e9a.asp
HSL6071
Pettengill K.
Autism Speaks
OpEdNews.com 2006 Sep 5
http://www.opednews.com/articles/genera_kendra_p_060905_autism_speaks.htm
HSL6012
Tougher regime for weight loss pills
Pharma In Focus 2006 Sep 4
http://www.pharmainfocus.com.au/news.asp?newsid=1321
HSL6096
Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, Haaijer-Ruskamp FM.
Determinants for the adoption of angiotensin II receptor blockers by general practitioners.
Soc Sci Med 2006 Sep 4;
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4KV2YCB-4&_coverDate=09%2F07%2F2006&_alid=453196199&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=566abe25312910ceb7e0510a437bef04
HSL6213
Lassen LC, Thomsen MK.
[Global health--the ethical responsibility of the pharmaceutical industry].
Ugeskr Laeger 2006 Sep 4;168:(36):2994-5
HSL6009
Medical Students And AARP Fight To End Gifts From Pharmaceutical Companies To Doctors
Medical News Today 2006 Sep 3
http://www.medicalnewstoday.com/medicalnews.php?newsid=51031&nfid=nl
HSL6010
Champion G.
Ritalin prescription fears raised : Children with the behavioural condition ADHD are continuing to be prescribed drugs such as Ritalin, despite an ongoing investigation.
BBC News 2006 Sep 3
http://newsvote.bbc.co.uk/mpapps/pagetools/print/news.bbc.co.uk/1/hi/scotland/5308292.stm
HSL6011
Cheng M.
New study raises concerns over the use of drug-coated coronary stents
Canadian Press 2006 Sep 3
http://ca.news.yahoo.com/s/03092006/2/xhealth-new-study-raises-concerns-use-drug-coated-coronary-stents.html
HSL7100
Pelosi AJ, McNulty SV, Jackson GA.
Role of cholinesterase inhibitors in dementia care needs rethinking.
BMJ 2006 Sep 2;333:(7566):491-3
http://www.bmj.com/cgi/content/short/333/7566/491
HSL7101
Aronson JK, Henderson G, Webb DJ, Rawlins MD.
A prescription for better prescribing.
BMJ 2006 Sep 2;333:(7566):459-60
http://www.bmj.com/cgi/content/full/333/7566/459
HSL5792
McNeill P.
Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia
Internal Medicine Journal 2006 Sep 1
http://www.blackwell-synergy.com/doi/full/10.1111/j.1445-5994.2006.01151.x
HSL5968
Cuzzolin L, Atzei A, Fanos V.
Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety.
Expert Opin Drug Saf 2006 Sep 01;5:(5):703-18
http://www.expertopin.com/doi/abs/10.1517/14740338.5.5.703
HSL6013
Flap Claims Journal Editor
SCIENCE ( The American Association for the Advancement of Science ) 2006 Sep 1
HSL6014
Doheny K.
Side Effects May Sideline New Osteoporosis Drugs
HealthDay News 2006 Sep 1
http://news.yahoo.com/s/hsn/20060901/hl_hsn/sideeffectsmaysidelinenewosteoporosisdrugs
HSL6016
Burcher S, Ho M.
FDA in Third World Drug Trial Scandals
Institute of Science in Society 2006 Sep 1
http://www.i-sis.org.uk/FDAinDrugTrial.php
HSL6070
Lehrman N.
The Dangers of Mental Health Screening
Journal of the American Physicians and Surgeons 2006 Sep 1
http://www.jpands.org/jpands1103.htm
HSL6093
Munoz C, Hilgenberg C.
Ethnopharmacology: understanding how ethnicity can affect drug response is essential to providing culturally competent care.
Holist Nurs Pract 2006 Sep-Oct 01;20:(5):227-34
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00004650-200609000-00004
HSL6094
Shrank WH, Joseph GJ, Choudhry NK, Young HN, Ettner SL, Glassman P, Asch SM, Kravitz RL.
Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?
Am J Manag Care 2006 Sep 01;12:(9):545-51
http://www.ajmc.com/Article.cfm?ID=3191&CFID=3768231&CFTOKEN=45537093
HSL6095
Carroll NV, Smith JC, Berringer RA, Oestreich GL.
Evaluation of an automated system for prior authorization: a COX-2 inhibitor example.
Am J Manag Care 2006 Sep 01;12:(9):501-8
http://www.ajmc.com/Article.cfm?ID=3187&CFID=3768231&CFTOKEN=45537093
HSL6112
Sleeping pills: are they worth the risk?
Consum Rep 2006 Sep 01;71:(9):48-9
HSL6128
Serdobova I, Kieny MP.
Assembling a global vaccine development pipeline for infectious diseases in the developing world.
Am J Public Health 2006 Sep 01;96:(9):1554-9
http://www.ajph.org/cgi/content/full/96/9/1554
HSL6208
Dubé G
Competing for the Retail Drug Market
Ottawa: Statistics Canada: Distributive Trades Division 2006 Sep 1
http://www.statcan.ca/english/research/11-621-MIE/11-621-MIE2006048.pdf
HSL6222
Fox MD.
Sleeping with the enemy: Garfield and the National Heart, Lung, and Blood Institute.
Pediatrics 2006 Sep 01;118:(3):1257-8
HSL6223
Tandon R.
Comparing antipsychotic efficacy.
Am J Psychiatry 2006 Sep 01;163:(9):1645
http://ajp.psychiatryonline.org/cgi/content/full/163/9/1645
HSL6224
Freedman R, Lewis DA, Michels R, Pine DS, Schultz SK, Tamminga C, Patterson SL, McIntyre JS, Goldman HH, Yudofsky SC, Hales RE, Rapaport MH, Hales D, Krajeski J, Kupfer DJ, Badaracco MA, Scully JH Jr.
Conflict of interest, round 2.
Am J Psychiatry 2006 Sep 01;163:(9):1481-3
http://ajp.psychiatryonline.org/cgi/content/full/163/9/1481
HSL6225
Akunyili D.
Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin.
Lancet Infect Dis 2006 Sep 01;6:(9):554-5
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(06)70575-8
HSL6226
Petty RE, Brinol P.
A metacognitive approach to 'implicit' and 'explicit' evaluations: comment on Gawronski and Bodenhausen (2006).
Psychol Bull 2006 Sep 01;132:(5):740-4
HSL6244
Shrank WH, Asch SM, Joseph GJ, Young HN, Ettner SL, Kholodenko Y, Glassman P, Kravitz RL.
Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs.
Ann Pharmacother 2006 Sep 01;40:(9):1534-40
http://www.theannals.com/cgi/content/full/40/9/1534
HSL6251
Stern RS.
Topical calcineurin inhibitors labeling: putting the 'box' in perspective.
Arch Dermatol 2006 Sep 01;142:(9):1233-5
http://archderm.ama-assn.org/cgi/content/full/142/9/1233
HSL6255
Weber K, Story M, Harnack L.
Internet food marketing strategies aimed at children and adolescents: a content analysis of food and beverage brand web sites.
J Am Diet Assoc 2006 Sep 01;106:(9):1463-6
http://linkinghub.elsevier.com/retrieve/pii/S0002-8223(06)01391-5
HSL6299
Lowe JA 3rd, Duckworth M, Jones P.
Innovation, productivity and the art of risk management.
Curr Opin Drug Discov Devel 2006 Sep 01;9:(5):549-50
HSL6300
Marris E.
Pfizer hires 'outsider' for insider top job.
Nat Rev Drug Discov 2006 Sep 01;5:(9):709
HSL6303
Krall RL, Rockhold F.
Reasons for optimism not disillusionment.
J R Soc Med 2006 Sep 01;99:(9):435
http://www.jrsm.org/cgi/content/full/99/9/435
HSL6305
Fehr A, Thurmann P, Razum O.
Editorial: drug development for neglected diseases: a public health challenge.
Trop Med Int Health 2006 Sep 01;11:(9):1335-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-3156.2006.01714.x
HSL6306
Liyanage SS, Raina Macintyre C.
Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
Health Info Libr J 2006 Sep 01;23:(3):214-22
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1471-1842.2006.00665.x
HSL6364
Paterson JM, Laupacis A, Bassett K, Anderson GM;.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Health Aff (Millwood). 2006 Sep 1;25:(5):1436-43
HSL6385
Diagnostic tests for HIV resistance are created as quickly as the new drugs. Research is leading individualized medicine evolution.
AIDS Alert 2006 Sep 01;21:(9):97-9
HSL6386
Kahn J.
Race, pharmacogenomics, and marketing: putting BiDil in context.
Am J Bioeth 2006 Sep-Oct 01;6:(5):W1-5
http://taylorandfrancis.metapress.com/(oixjarzvu5bbwwilaz5wcvij)/app/home/contribution.asp?referrer=parent&backto=issue,28,33;journal,1,27;linkingpublicationresults,1:111605,1
HSL6387
Kearney G.
Strategic questioning the way to shift opinion.
Aust Nurs J 2006 Sep 01;14:(3):44
HSL6389
Bosmans JM, Spinhoven MJ, Deckers FP, Pouillon MM, Borre FJ, Parizel PM.
Accidental ingestion of a press-through package: an underestimated cause of serious iatrogenic disease in the elderly?
J Am Geriatr Soc 2006 Sep 01;54:(9):1467-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1532-5415.2006.00858.x
HSL7559
Young D.
Safety nets still overpaying for drugs.
Am J Health Syst Pharm 2006 Sep 1;63:(17):1584,
http://www.ajhp.org/cgi/content/full/63/17/1584
HSL8144
Burkette S.
Alternative Media: The Download on Podcasting
Pharmaceutical Executive 2006 Sep 1
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=369281&pageID=1
HSL19787
Eccies K
Divisions' bid to take over pharma education a hard sell
Medical Observer 2006 Sep 1
HSL20055
Anastasopoulos C
ADGP spruiks for 'party plan' role
Australian Doctor 2006 Sep 16
HSL6220
Ahmad K.
Abbott accused of refusing access to HIV drug.
Lancet Infect Dis 2006 Sep;6:(9):547
HSL6221
Twery MJ.
The cartoon character garfield and the 'sleep well. Do well. Star sleeper' campaign.
Pediatrics 2006 Sep;118:(3):1259
HSL7493
Sternon J.
[The war on generic drugs]
Rev Med Brux. 2006 Sep-Oct;;27:(5):420-1
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17176536&dopt=Abstract
HSL7507
Stolk P, Willemen MJ, Leufkens HG.
Rare essentials: drugs for rare diseases as essential medicines.
Bull World Health Organ 2006 Sep;84:(9):745-51
HSL7508
Reidenberg MM.
Are drugs for rare diseases "essential"?
Bull World Health Organ 2006 Sep;84:(9):686
HSL7516
Reidak A.
Were Eli Lilly unaware of this study?
PLoS Med 2006 Sep;3:(9):e408
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030408
HSL7518
Tormala ZL, Clarkson JJ, Petty RE.
Resisting persuasion by the skin of one's teeth: the hidden success of resisted persuasive messages.
J Pers Soc Psychol 2006 Sep;91:(3):423-35
http://content.apa.org/journals/psp/91/3/423
HSL7522
Pawlotsky JM.
Science, medicine and the markets.
J Hepatol 2006 Sep;45:(3):341-2
http://linkinghub.elsevier.com/retrieve/pii/S0168-8278(06)00340-0
HSL7542
Goni S.
[Divided responsibilities: Role of industry.]
Encephale 2006 Sep;32:
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=539&CodeRevue4=ENC&Path=REVUE/ENC/2006/32/4C3/ARTICLE11574617826.xml&Locations=
HSL7546
Dossey L.
Listerine's long shadow: disease mongering and the selling of sickness.
Explore (NY) 2006 Sep-Oct;2:(5):379-85
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16979097&dopt=Abstract
HSL7551
Wang M, Chen Y.
Age differences in attitude change: influences of cognitive resources and motivation on responses to argument quantity.
Psychol Aging 2006 Sep;21:(3):581-9
http://content.apa.org/journals/pag/21/3/581
HSL7553
O'Connell D, Roblin D.
Translational research in the pharmaceutical industry: from bench to bedside.
Drug Discov Today 2006 Sep;11:(17-18):833-8
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T64-4KRFS3R-B&_coverDate=09%2F30%2F2006&_alid=528326543&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5020&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=571ec392e21d22a997f70573612ddae6
HSL7556
Schmid EF, Smith DA.
R&D technology investments: misguided and expensive or a better way to discover medicines.
Drug Discov Today? 2006 Sep;11:(17-18):775-84
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16935744&dopt=Abstract
HSL7560
de Pouvourville G.
Risk-sharing agreements for innovative drugs: a new solution to old problems?
Eur J Health Econ 2006 Sep;7:(3):155-7
http://www.springerlink.com/content/9v40j71827xl2635/
HSL7561
Lott JP, Katz KA.
Pharmaceutical companies' policies and practices regarding prospective registration of dermatology-related clinical trials.
Br J Dermatol. 2006 Sep;155:(3):635-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2006.07386.x
HSL7565
Dalen DM, Strom S, Haabeth T.
Price regulation and generic competition in the pharmaceutical market.
Eur J Health Econ 2006 Sep;7:(3):208-14
http://www.springerlink.com/content/t385365538697l50/
HSL7582
Schrank B, Seyringer ME, Berger P, Katschnig H, Amering M.
[Schizophrenia and psychosis on the internet ]
Psychiatr Prax. 2006 Sep;33:(6):277-81
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2005-915320
HSL7591
de Lorgeril M, Salen P.
Cholesterol lowering and mortality: time for a new paradigm?
Nutr Metab Cardiovasc Dis 2006 Sep;16:(6):387-90
http://linkinghub.elsevier.com/retrieve/pii/S0939-4753(06)00124-4
HSL7671
Brewer GJ.
Fundamental problems lie ahead in the drug discovery and commercialization
process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
J Investig Med 2006 Sep;54:(6):291-302
http://www.bcdecker.com/pubMedLinkOut.aspx?pub=JIMO&vol=54&iss=6&page=291
HSL7690
Hall W.
Ensuring that addiction science is deserving of public trust.
Addiction 2006 Sep;101:(9):1223-4
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1360-0443.2006.01552.x
HSL8019
Dormont B, Grignon M, Huber H.
Health expenditure growth: reassessing the threat of ageing.
Health Econ 2006 Sep;15:(9):947-63
http://www3.interscience.wiley.com/cgi-bin/abstract/112776605/ABSTRACT?CRETRY=1&SRETRY=0
HSL8049
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol. 2006 Sep;13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9
HSL8050
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol. 2006 Sep;13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9
HSL8051
Mathez P, Chapuis S.
[Blood transfusion and advertising].
Transfus Clin Biol 2006 Sep;13:(3):211-4
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VN7-4KVXHWM-1&_user=10&_coverDate=09%2F30%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0393582c6798cca1a65f4bbb56743ad9
HSL8212
Courcier S, Sibenaler C, Couderc M, Trinquet F, Pletan Y, Lassale C; Groupe de travail attractivite de la France du Leem.
[The attractive position of France in international clinical research: 2006 survey assessed by Leem (French pharmaceutical companies)].
Therapie 2006 Sep-Oct;61:(5):407-18
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17243270&query_hl=10&itool=pubmed_DocSum
HSL8315
Myhr G, Payne K.
Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada.
Can J Psychiatry 2006 Sep;51:(10):662-70
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17052034&query_hl=2&itool=pubmed_DocSum
HSL8683
Fisher JA.
Co-ordinating 'ethical' clinical trials: the role of research coordinators in the contract research industry.
Sociol Health Illn 2006 Sep;28:(6):678-94
http://www.blackwell-synergy.com/doi/full/10.1111/j.1467-9566.2006.00536.x
HSL8733
Mani MK.
Advertising again.
Natl Med J India 2006 Sep-Oct;19:(5):287-8
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203687&query_hl=16&itool=pubmed_DocSum
HSL8734
George T, Srinivasan S.
Does the TGN1412 trial disaster have lessons for clinical trials in India?
Natl Med J India 2006 Sep-Oct;19:(5):283-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17203685&query_hl=18&itool=pubmed_DocSum
HSL8748
Booth RE Jr.
Truth in advertising: the ethical limits of direct-to-consumer marketing.
Orthopedics 2006 Sep;29:(9):780-1
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17004586&query_hl=2&itool=pubmed_DocSum
HSL9002
Meadows M, Weitzman M.
Advancing public health through partnerships.
FDA Consum 2006 Sep-Oct;40:(5):27-36
http://www.fda.gov/fdac/features/2006/506_partnerships.html
HSL9024
Hilbrich L, Sleight P.
Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
Eur Heart J 2006 Sep;27:(18):2158-64
http://eurheartj.oxfordjournals.org/cgi/content/full/27/18/2158
HSL9109
Gebhardt DO.
The generic-patent medicine conflict flares up again in The Netherlands.
J Med Ethics 2006 Sep;32:(9):555
http://jme.bmj.com/cgi/content/full/32/9/555
HSL12178
De Vries R, Elliott C.
Why disclosure?
J Gen Intern Med 2006 Sep;21:(9):1003-4
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16918750
HSL12247
Tomaszewski C.
Off-label: just what the doctor ordered.
J Med Toxicol 2006 Sep;2:(3):87-8
http://www.ncbi.nlm.nih.gov/pubmed/18072123
HSL6017
Cassels A.
Big Pharma holds drug and advocacy groups hostage
Common Ground 2006 Aug 31
http://www.commonground.ca/iss/0609182/cg182_Cassels.shtml
HSL6019
Pringle E.
Big Pharma Bankrupting US Health Care System
OpEdNews.com 2006 Aug 31
http://www.opednews.com/articles/genera_evelyn_p_060831_big_pharma_bankrupti.htm
HSL6021
Reischel J.
In Cord Blood : Turning the miracle of birth into the banking of cold, hard cash.
New Times B-PB 2006 Aug 31
http://www.newtimesbpb.com/Issues/2006-08-31/news/feature_full.html
HSL6020
Pringle E.
Spotlight Focused On Pfizer's Lipitor Follies
Scoop Independent News 2006 Aug 30
http://www.scoop.co.nz/stories/HL0608/S00363.htm
Page 105 of 206 pages ‹ First < 103 104 105 106 107 > Last ›
